Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | PTPRC | P08575 | 1/20 | 0.39 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19463069 | 0.82 | HDAC8 (0.54) | L3MBTL1KMT2AALDH1A1MEN1HTT | |
| SCHEMBL24239916 | 0.78 | CA12 (0.51) | L3MBTL1KMT2APOLBALDH1A1MEN1 | |
| SCHEMBL17570931 | 0.77 | RECQL (0.47) | L3MBTL1KMT2AMEN1PTPRCPTPN13 | |
| SCHEMBL2711919 | 0.76 | KMT2A (0.49) | L3MBTL1KMT2APOLBALDH1A1MEN1 | |
| SCHEMBL13223975 | 0.76 | HSP90AB1 (0.39) | L3MBTL1KMT2APOLBALDH1A1MEN1 | |
| SCHEMBL29329240 | 0.76 | ALDH1A1 (0.44) | L3MBTL1KMT2AALDH1A1MEN1HTT | |
| SCHEMBL21029724 | 0.75 | LMNA (0.54) | L3MBTL1KMT2APOLBALDH1A1MEN1 | |
| SCHEMBL22987302 | 0.74 | KDM4E (0.38) | L3MBTL1KMT2APOLBALDH1A1MEN1 | |
| SCHEMBL3142093 | 0.74 | HPGD (0.45) | L3MBTL1KMT2APOLBALDH1A1MEN1 | |
| SCHEMBL21029725 | 0.72 | MAPT (0.34) | L3MBTL1KMT2APOLBALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043833-B2 | Targeted compositions | ARBUTUS BIOPHARMA CORPORATION (CA) | 2024-07-23 | — | — | US | disclosed |